K-V PHARMACEUTICAL Aktie

1,32 USD 34,6939%

Zu Ihrem Onlinebroker

kaufen verkaufen

K-V PHARMACEUTICAL Aktienkurs : 25.05. ( 15 Min. verzögert)
1,32 $ Letzter Kurs	34,69% Veränderung	0,980 $ Vortag	1,000 $ Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
1,55 - 0,990 Tag	4,29 - 0,790 52 Wochen	2.919.724 Tag	920.385 Ø 52 Wochen	1,12 500 Stücke	1,37 2.000 Stücke

K-V PHARMACEUTICAL Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

26.05.

Perrigo approved to market generic version of yeast infection fighter Gynazole

That is the generic equivalent of KV Pharmaceutical Co.'s Gynazole 1 vaginal cream, 2%, The antifungal medication is a cream treatment for vulvovaginal candidiasis (vaginal yeast infections) from…
26.05.

NYSE stocks posting largest volume increases

KV Pharmaceutical Co. class B : Approximately 28900 shares changed hands, a 730.5 percent increase over its 65-day average volume. The shares rose $.22 or 18.6 percent to $1.38. KV Pharmaceutical Co.…

25.05.

K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual ...

LOUIS, May 25, 2012 -- /PRNewswire/ -- KV Pharmaceutical Company (the "Company") (NYSE: KVa/KVb) today announced that in view of the unusual market activity in the Company's common stoc…
23.05.

Perrigo's Generic Portfolio Boosted

Good news flowed in at Perrigo Company (PRGO - Analyst Report) when the US Food and Drug Administration (FDA) cleared its generic version of KV Pharmaceutical Company's vaginal cream Gynazole·1. …
18.05.

Alkermes (NASDAQ:ALKS) Posts Loss 4Q on Elan Deal, Revenue Jumps- ALKS, VRX ...

Turning towards the investors who viewing ALSK against Valeant Pharmaceuticals Int (USA) (NYSE:VRX) declined -1.79%, Elan Corporation, plc (ADR) (NYSE:ELN) lost -2.03%, Hospira, Inc. (NYSE:HSP) slid …